Article
Broad activation of latent HIV-1 in vivo
8 Sept 2016
Abstract excerpt
The 'shock and kill' approach to cure human immunodeficiency virus (HIV) includes transcriptional induction of latent HIV-1 proviruses using latency-reversing agents (LRAs) with targeted immunotherapy to purge infected cells. The administration of LRAs (panobinostat or vorinostat) to HIV-1-infected individuals on antiretroviral therapy induces a significant increase in cell-associated unspliced (CA-US) HIV-1 RNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
